Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.41 |
| ▸ | MEN1 | O00255 | 2/20 | 0.41 |
| ▸ | LMNA | P02545 | 3/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.41 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.41 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.41 |
| ▸ | DAO | P14920 | 1/20 | 0.40 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | TP53 | P04637 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18347410 | 0.95 | SMN1; SMN2 (0.47) | SMN1; SMN2KMT2AMEN1LMNAALDH1A1 | |
| SCHEMBL18347395 | 0.95 | SMN1; SMN2 (0.47) | SMN1; SMN2KMT2AMEN1LMNAALDH1A1 | |
| SCHEMBL18347400 | 0.88 | SMN1; SMN2 (0.39) | SMN1; SMN2KMT2AMEN1LMNAALDH1A1 | |
| SCHEMBL18347403 | 0.86 | TP53 (0.46) | SMN1; SMN2MAPK1DAOTP53L3MBTL1 | |
| SCHEMBL18347407 | 0.83 | SMN1; SMN2 (0.38) | SMN1; SMN2KMT2AMEN1LMNAALDH1A1 | |
| SCHEMBL18347401 | 0.83 | MEN1 (0.40) | SMN1; SMN2KMT2AMEN1LMNAALDH1A1 | |
| SCHEMBL18347409 | 0.82 | TP53 (0.38) | SMN1; SMN2ALDH1A1DAOTP53 | |
| SCHEMBL18347391 | 0.82 | TP53 (0.38) | SMN1; SMN2ALDH1A1DAOTP53 | |
| SCHEMBL18347404 | 0.81 | SMN1; SMN2 (0.36) | SMN1; SMN2KMT2AMEN1ALDH1A1DAO | |
| SCHEMBL18347390 | 0.81 | TP53 (0.44) | SMN1; SMN2ALDH1A1DAOTP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160376248-A1 | METHOD FOR PRODUCING HETEROARYLCARBOXYLIC ACID ESTER DERIVATIVE, AND PRODUCTION INTERMEDIATE OF SAME | EA PHARMA CO., LTD. (JP) | 2016-12-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160376248-A1 | METHOD FOR PRODUCING HETEROARYLCARBOXYLIC ACID ESTER DERIVATIVE, AND PRODUCTION INTERMEDIATE OF SAME | CYP4A11, INSR, CYP2C9 | SMN1; SMN2 4730/4885KMT2A 2461/4885MEN1 1977/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.